Post-earnings recap
Reported
Thu, Feb 13, 2025
EPS actual
$2.90
EPS est.
$2.92
EPS surprise
-0.85%
1-day move
-1.92%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad's earnings report shows a slight miss on EPS, which contributed to a 1.92% decline in stock price. The lack of revenue data and guidance may have left investors uncertain about the company's future performance. Management's cautious optimism suggests they are aware of market challenges but are focused on long-term strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.90 | N/A | -0.85% |
Overall, management acknowledged current market pressures while emphasizing their commitment to future growth through innovation.
Management noted ongoing challenges in the market but expressed confidence in long-term growth.
They highlighted the importance of innovation in maintaining competitive advantage.